Industry Discovery & Development Partnership (IDDP) Program
Breakthrough T1D’s IDDP Program funds for-profit companies to advance research and development of therapies or devices for type 1 diabetes, with a focus on projects ready for commercialization.
Funder: Breakthrough T1D
Due Dates: Rolling (LOIs accepted year-round; timelines set per project or RFA)
Funding Amounts: Flexible; award size and duration negotiated per project. Matching funds from the company are required.
Summary: Supports for-profit companies conducting research on type 1 diabetes that aligns with Breakthrough T1D’s strategic priorities, with the goal of advancing commercially viable therapies or devices.
Key Information: Applicants must contact Breakthrough T1D staff before submitting an LOI; company matching funds required.
Description
The Industry Discovery & Development Partnership (IDDP) Program from Breakthrough T1D provides funding and collaborative support to for-profit entities—such as biotechnology, pharmaceutical, and device companies—pursuing research projects that are closely aligned with Breakthrough T1D’s priority research areas in type 1 diabetes (T1D). The aim is to accelerate the discovery, development, and commercialization of therapeutics and devices that prevent, treat, or cure T1D by leveraging both commercial and scientific expertise. Projects should have a clear path toward product development with strong potential for impact on the T1D community.
